久久天天躁狠狠躁夜夜AV,久久精品国产一区二区电影,国产中年熟女高潮大集合

規格	庫存	目錄價	會員專享價	數量
10 mg	3-5days	￥600.00	登錄后可見	- +
25 mg	3-5days	￥980.00	登錄后可見	- +
50 mg	3-5days	￥1568.00	登錄后可見	- +

規格

庫存

目錄價

會員專享價

數量

10 mg

3-5days

￥600.00

登錄后可見

- +

25 mg

3-5days

￥980.00

登錄后可見

- +

50 mg

3-5days

￥1568.00

登錄后可見

- +

基本信息

英文名稱	Crizotinib hydrochloride \| PF-02341066 hydrochloride
中文名稱	鹽酸克里唑替尼
CAS號	1415560-69-8
分子式	C21H23Cl3FN5O
分子量	486.80
外觀	Yellow to brown powder
儲存條件	4°C, sealed storage, away from moisture

安全信息

產品詳情

Crizotinib HCl (formerly known as PF-02341066 hydrochloride; trade name: Xalkori) is a potent, orally bioavailable small molecule inhibitor of c-Met and ALK, with IC50 values of 11 nM and 24 nM in assays involving cells, respectively. In the US, crizotinib is licensed for the treatment of non-small cell lung cancer (NSCLC). It is also being investigated in clinical trials for safety and effectiveness in the treatment of neuroblastoma, anaplastic large cell lymphoma, and other advanced solid tumors in both adults and children. Crizotinib inhibits the activation of the MET signaling pathway and the membrane receptor MET, which in susceptible tumor cell populations may prevent tumor cell growth, migration, invasion, and angiogenesis.

PMID: 17483355 DOI: 10.1158/0008-5472.CAN-06-4443

PMID: 21812414 DOI: 10.1021/jm2007613

Mol Cancer Ther. 2007, 6(12 Pt 1), 3314-3322.

相關產品